*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Atlanta, GA | Posted: March 10, 2013
The American Institute for Medical and Biological Engineering (AIMBE) has named Ravi Bellamkonda as the organization’s president-elect. He will begin his term as president in 2014.
Bellamkonda represents the fourth Georgia Tech bioengineer elected to serve as president of the prestigious organization, reflecting the Institute’s leadership in biological and medical engineering. He follows in the footsteps of Georgia Tech’s Robert Nerem, Don Giddens and Larry McIntire.
Bellamkonda is the Carol Ann and David D. Flanagan Chair in Georgia Tech and Emory University’s Wallace H. Coulter Department of Biomedical Engineering (BME), where he directs the Neurological Biomaterials and Cancer Therapeutics Laboratory. He also serves as Georgia Tech’s associate vice president for research and is a Georgia Cancer Coalition Distinguished Scholar.
Headquartered in in Washington, D.C., AIMBE provides leadership and advocacy in medical and biological engineering.
